TCM

TCG Crossover Management Portfolio holdings

AUM $876M
This Quarter Return
+42.58%
1 Year Return
+23.66%
3 Year Return
+996.72%
5 Year Return
–
10 Year Return
–
AUM
$1.26B
AUM Growth
+$1.26B
Cap. Flow
+$278M
Cap. Flow %
21.99%
Top 10 Hldgs %
58.32%
Holding
38
New
9
Increased
5
Reduced
7
Closed
5

Top Buys

1
CGON icon
CG Oncology
CGON
$157M
2
ATXS icon
Astria Therapeutics
ATXS
$74.3M
3
KROS icon
Keros Therapeutics
KROS
$58.2M
4
OCUL icon
Ocular Therapeutix
OCUL
$48.4M
5
EWTX icon
Edgewise Therapeutics
EWTX
$41.5M

Top Sells

1
ICVX
Icosavax, Inc. Common Stock
ICVX
$58.4M
2
RYZB
RayzeBio, Inc. Common Stock
RYZB
$54.1M
3
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$45.3M
4
KALV icon
KalVista Pharmaceuticals
KALV
$26.5M
5
GPCR icon
Structure Therapeutics
GPCR
$21.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KALV icon
26
KalVista Pharmaceuticals
KALV
$713M
$13.8M 1.09%
1,163,356
-2,232,139
-66% -$26.5M
CCCC icon
27
C4 Therapeutics
CCCC
$182M
$10.4M 0.82%
1,276,574
– –
TRDA icon
28
Entrada Therapeutics
TRDA
$202M
$8.29M 0.66%
584,955
– –
ANTX icon
29
AN2 Therapeutics
ANTX
$35.3M
$5.05M 0.4%
1,555,118
-1,123,091
-42% -$3.65M
KOD icon
30
Kodiak Sciences
KOD
$453M
$4.73M 0.37%
899,999
+632,058
+236% +$3.32M
VTYX icon
31
Ventyx Biosciences
VTYX
$184M
$4.49M 0.35%
815,724
– –
NKTR icon
32
Nektar Therapeutics
NKTR
$543M
$3.74M 0.3%
+266,667
New +$3.74M
CABA icon
33
Cabaletta Bio
CABA
$144M
$1.48M 0.12%
86,795
-400,000
-82% -$6.82M
NRIX icon
34
Nurix Therapeutics
NRIX
$723M
– –
-717,654
Closed -$7.41M
TSHA icon
35
Taysha Gene Therapies
TSHA
$791M
– –
-2,912,861
Closed -$5.16M
RYZB
36
DELISTED
RayzeBio, Inc. Common Stock
RYZB
– –
-869,908
Closed -$54.1M
GRCL
37
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
– –
-4,514,786
Closed -$45.3M
ICVX
38
DELISTED
Icosavax, Inc. Common Stock
ICVX
– –
-3,703,704
Closed -$58.4M
1
2